The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share
June 19, 2025 16:05 ET Â | Source: The Ensign Group, Inc. SAN…
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
June 19, 2025 01:00 ET Â | Source: Addex Therapeutics Strong cash position…
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares
June 18, 2025 17:36 ET Â | Source: Psyence Group Inc. TORONTO, June…
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
June 18, 2025 16:30 ET Â | Source: Cellectar Biosciences, Inc. FLORHAM PARK,…
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
June 18, 2025 01:00 ET Â | Source: Addex Therapeutics Geneva, Switzerland, June…
Explore Changping: Where Ming Dynasty Heritage Meets Modern Adventure
CHANGPING, China, June 17, 2025 /PRNewswire/ -- On June 14, the Ming…
Llusern Scientific Announces ISO 13485 Certification for itsPoint-of-Care Diagnostics System for Urinary Tract Infections
June 17, 2025 04:00 ET Â | Source: Llusern Scientific CARDIFF, United Kingdom,…
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
June 17, 2025 02:00 ET Â | Source: Orion Oyj ORION CORPORATION PRESS…
VERSES Signs Soothsayer Analytics As First Genius Reseller and Fortune 500 Integrator
Agreement to accelerate global enterprise adoption of Genius through sales, training, certification,…
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 14, 2025 10:48 ET Â | Source: Celldex Therapeutics, Inc. 77% of…